A Type IV Modification-dependent Restriction Enzyme SauUSI from Staphylococcus Aureus Subsp. Aureus USA300
Overview
Affiliations
A gene encoding a putative DNA helicase from Staphylococcus aureus USA300 was cloned and expressed in Escherichia coli. The protein was purified to over 90% purity by chromatography. The purified enzyme, SauUSI, predominantly cleaves modified DNA containing 5mC and 5-hydroxymethylcytosine. Cleavage of 5mC-modified plasmids indicated that the sites S5mCNGS (S = C or G) are preferentially digested. The endonuclease activity requires the presence of adenosine triphosphate (ATP) or dATP whereas the non-hydrolyzable γ-S-ATP does not support activity. SauUSI activity was inhibited by ethylenediaminetetraacetic acid. It is most active in Mg(++) buffers. No companion methylase gene was found near the SauUSI restriction gene. The absence of a cognate methylase and cleavage of modified DNA indicate that SauUSI belongs to type IV restriction endonucleases, a group that includes EcoK McrBC and Mrr. SauUSI belongs to a family of highly similar homologs found in other sequenced S. aureus, S. epidermidis and S. carnosus genomes. More distant SauUSI orthologs can be found in over 150 sequenced bacterial/archaea genomes. Finally, we demonstrated the biological function of the type IV REase in restricting 5mC-modified plasmid DNA by transformation into clinical S. aureus strain SA564, and in restricting phage λ infection when the endonuclease is expressed in E. coli.
Nucleic acid recognition during prokaryotic immunity.
Baca C, Marraffini L Mol Cell. 2025; 85(2):309-322.
PMID: 39824170 PMC: 11750177. DOI: 10.1016/j.molcel.2024.12.007.
Kornienko M, Bespiatykh D, Abdraimova N, Gorodnichev R, Gostev V, Boldyreva D Sci Rep. 2024; 14(1):29375.
PMID: 39592862 PMC: 11599779. DOI: 10.1038/s41598-024-80909-x.
Altered genomic methylation promotes Staphylococcus aureus persistence in hospital environment.
Yamazaki Y, Ito T, Nakagawa S, Sugihira T, Kurita-Tachibana C, Villaruz A Nat Commun. 2024; 15(1):9619.
PMID: 39511195 PMC: 11544029. DOI: 10.1038/s41467-024-54033-3.
An enterococcal phage protein inhibits type IV restriction enzymes involved in antiphage defense.
Bullen N, Johnson C, Andersen S, Arya G, Marotta S, Lee Y Nat Commun. 2024; 15(1):6955.
PMID: 39138193 PMC: 11322646. DOI: 10.1038/s41467-024-51346-1.
Bullen N, Johnson C, Andersen S, Arya G, Marotta S, Lee Y bioRxiv. 2023; .
PMID: 38014348 PMC: 10680825. DOI: 10.1101/2023.11.16.567456.